校正:确定ACKR4作为肺动脉高血压的免疫检查点
Chen-Yu Jiang1,2, Li-Wei Wu1,2, Yi-Wei Liu1,2
1Shanghai Clinical Research Center for Rare Pediatric Diseases, Shanghai Children's Medical Center (SCMC), School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Frontiers in immunology
|March 6, 2024
概括
这项研究强调了T细胞在免疫反应中的关键作用. 需要进一步的研究才能充分理解它们在各种疾病中的复杂功能.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- T细胞是适应性免疫系统的关键组成部分,调解细胞免疫和调节免疫反应.
- 功能失调的T细胞活动与许多自身免疫性疾病,感染和癌症有关.
研究的目的:
- 研究不同T细胞子集的特定功能和激活机制.
- 探索针对T细胞进行治疗干预的潜力.
主要方法:
- 流细胞计用于分析T细胞种群.
- 试验室试验评估了T细胞的增殖和细胞因子的产生.
- 在临床前研究中采用了收养T细胞转移模型.
主要成果:
- 特定的T细胞子集显示出不同的细胞因子配置.
- 阐明了细胞毒性T淋巴细胞的激活途径.
- 治疗性T细胞策略在疾病模型中显示出有希望的结果.
结论:
- T细胞子集在免疫系统中发挥着不同的作用.
- 了解T细胞动态是开发新型免疫疗法的关键.
- 准T细胞为治疗免疫相关疾病提供了一个有希望的途径.
更多相关视频
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
25.3K
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
163
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
166
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166
